Events and Exhibitions

NextDocs User Conference in Japan Focuses on the Power of SharePoint and Regulated Content Management

CONSHOHOCKEN, Pa. and Tokyo, Aug. 1, 2013 /PRN KYODO JBN/ –

The growing challenges to life sciences and pharmaceutical companies,
particularly in drug development, and the “technology paradigm shift” that is
taking place in the industry, were among the featured areas of discussion at
the NextDocs Japanese User Conference in Osaka and Tokyo, Japan last month.
The NextDocs Japanese User Conference is the premier SharePoint conference for
the life sciences industry in the Asia-Pac region, attended by senior business
professionals from more than 100 life sciences and pharmaceutical companies, as
well as related service providers.

The conference included an address by Masao Yanagisawa, Manufacturing
Industry Market Development Manager, Industry Partner Sales Group at
Microsoft.  Yanagisawa discussed the headwinds challenging the industry,
including certain changes in the patient population, the escalating cost of
drug development, increasing regulation and patent expirations.  He also
discussed how the Microsoft SharePoint family of products can provide
businesses a modern document management and collaboration platform which is
essential to face these challenges.

Chiemi Kamakura, Director for Japan with NextDocs also addressed the
conference.  She discussed the company’s strong expansion in Japan – and
detailed the capabilities of NextDocs 6, the latest version of the company’s
award-winning regulated content management and compliance solution suite.
Kamakura noted, “With five of the top 10 pharmaceutical companies and two of
the largest CROs relying on NextDocs solutions, the platform is on track to
become the industry standard for regulated content management.”

Kamakura also outlined an ongoing “technology paradigm shift” in which life
sciences companies are shifting from legacy systems. She noted that mobile,
cloud and analytics solutions currently account for 20 percent of IT spend at
life sciences companies, but that number is expected to rise to 80 percent in
the next six years.  She also referenced a survey conducted by NextDocs in
which nearly 37 percent of life sciences companies reported scaling back or
replacing their legacy systems, such as EMC Documentum – and in which 65
percent of life sciences companies reported plans to shift to Microsoft
SharePoint-based content management systems.

The conference also featured presentations by executives from Sanofi on
regulated content management in clinical trial environments, and Santen on
global implementation of regulatory submission documents management system.


Dan Cahill